if you become pregnant whilst on treatment, stop the medication and seek immediate medical and nutritional review [1] [25] Contact your GP urgently if you experience: Severe, persistent abdominal pain (with or without vomiting) which could indicate pancreatitis Upper-right abdominal pain, fever or jaundice which may suggest gallbladder disease Persistent nausea or vomiting preventing adequate nutrition Signs of dehydration (dark urine, dizziness, reduced urination) Unexplained symptoms such as jaundice, severe fatigue, or mood changes For people with diabetes: hypoglycaemia (low blood sugar) symptoms when taking insulin or sulfonylureas alongside GLP-1 therapy Regular monitoring throughout GLP-1 treatment should include periodic assessment of weight, body composition where possible, nutritional intake, and relevant blood markers
Mice deficient in hepsin, a serine protease, exhibit normal embryogenesis and unchanged hepatocyte regeneration ability
All peptides work this way
Cycle structure: Weeks 1-2: Adaptation phase (increased recovery, enhanced nutrient uptake) Weeks 3-4: Peak anabolic phase (maximum muscle protein synthesis, strength increases) Weeks 5-6: Maintenance/plateau phase (receptor sensitivity declining) Week 7+: Diminishing returns (not recommended) Post-Cycle Recovery: Unlike steroids, IGF-1 LR3 doesn't suppress natural hormone production